Health Care

Shares Reports Bring Up To Date: Merck & Company, Inc. (NYSE:MRK), Inovio Pharmaceuticals, Inc. (NASDAQ:INO)

0 6

Merck & Company, Inc. (NYSE:MRK) closed its last session at $59.35 with the change of +0.97%. The market capitalization of the company is $164.28B with an average Volume of 8.91 million shares. The stock currently has its 52-Week High range of $60.07 and 52-week low range of $45.69. The Price to Book (P/B) ratio stands at 3.72. The stock traded total quantity of 9.48 million shares.

For the current Fiscal Quarter, 16 analysts have given an average earnings per share forecast of $0.91. The Low Earnings per share estimate of the current Quarter is $0.89 and High Estimate is set at $0.94 according to these Analysts opinions. The Previous Year EPS of this Quarter is $0.86.

According to 13 analysts, an average sales Estimate of the current Fiscal quarter is $9.79B. The lower sales estimate is $9.61B and higher sales estimate is $10.02B according to these Analysts thoughts.

The Company currently has Highest Price Target of $80 and Lowest Price Target of $50. It has Median Price Targets of $61.5. Mean price target is set at $61.45 after consensus analysis of 20 brokers.

When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 2 analysts have assigned this stock as Strong Buy where 7 assigned Buy, 13 analysts believe it’s a Hold, 0 said Underperform and 0 assigned Sell rating.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) ended its last trade at $9.11 with the move of +0.33%. The company has market value of $665.91M with the total traded volume of 1.44 million. The stock currently has its 52-Week top value of $11.69 and 52-week down value of $4.50. The price to book (P/B) ratio of the company is 3.84. Its previous closing price was recorded at $9.08.

For the current Fiscal Quarter, 5 analysts have given an Average earnings estimate of $-0.21 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $-0.28 while High Estimate is $0. The Previous Year EPS of this Quarter is $-0.09.

 

According to 4 analysts, an Average Revenue Estimate of the current Fiscal quarter is $4.95M. According to them, the Low Revenue estimate is $3.12M and High Revenue estimate is $5.76M.

 

The Company currently has High Price Target of $18. The Low and Mean Price Targets are $13 and $15.5 respectively. These price targets are set after consensus analysis of 4 brokers.

 

When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 2 analysts have given this stock as Strong Buy where 3 issued Buy, 0 analysts think that it’s a Hold, 0 told Underperform and0 assigned Sell rating.

 

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter